Skip to main content

Table 3 Change in follow-up variables at 3, 6, and 12 months after the baseline visit among all participants, by smoking status (continuous abstinence vs. relapse)

From: Leptin and smoking cessation: secondary analyses of a randomized controlled trial assessing physical activity as an aid for smoking cessation

 

3 months

 

6 months

 

12 months

 
 

Smoking

Abstinence

p

Smoking

Abstinence

p

Smoking

Abstinence

p

Body weight [Kg]

2.25 (2.35)

1.99 (2.83)

0.584

3.05 (4)

2.45 (6.15)

0.599

2.45 (3.64)

3.2 (7.42)

0.520

BMI [kg/m2]

0.78 (0.89)

0.68 (0.95)

0.539

1.08 (1.44)

0.86 (1.87)

0.535

0.84 (1.2)

1.1 (2.29)

0.468

Body fat [%]

1.49 (3.19)

1.23 (4)

0.784

2.18 (3.1)

2.09 (6.01)

0.955

2.5 (2.84)

2.57 (5.47)

0.948

HOMA-IR

0.1 (1.56)

0.03 (1.03)

0.763

0.27 (1.2)

0.27 (0.93)

0.977

0.99 (2.32)

0.83 (1.54)

0.681

Fasting leptin [ug/l]

1.8 (4.3)

2.03 (3.67)

0.734

1.88 (6.82)

2.63 (4.59)

0.505

1.83 (4.14)

2.56 (5.44)

0.455

Ratio leptin/body fat

0 (0.15)

0.03 (0.17)

0.513

-0.02 (0.18)

0.02 (0.22)

0.529

0 (0.11)

0.03 (0.24)

0.564

  1. Values are expressed in means (standard deviation).